DERIVE DE 2-CYANOPYRIMIDIN-4-YL CARBAMATE OU D'UREE OU SEL DE CELUI-CI ET COMPOSITION PHARMACEUTIQUE LE COMPRENANT

• 收藏
• 分享

专利权人:

HANLIM PHARMACEUTICAL CO.; LTD.

发明人:

KIM, KYUNG-HEE,CHIN, JUNG-WOOK,LEE, JI-HOON,KIM, SHIN-AE,JUNG, KYUNG-JIN,KIM, JUN-WOO,MIN, SANG-HYUN,YU, JI-HOON,LEE, JU-SUK,LEE, WON-SEOK,SONG, JAE-YOUNG,LEE, EUNG-SEOK,JEONG, TAE-CHEON,KIM, JUNG-AE

申请号：

CA3093546

公开号：

CA3093546A1

申请日:

2019.03.20

申请国别(地区):

CA

年份:

2019

代理人:

摘要：

The present invention provides a 2-cyanopyrimidin-4-yl carbamate or urea derivative or a pharmaceutically acceptable salt thereof, a method for preparing same, and a pharmaceutical composition including same. The 2-cyanopyrimidin-4-yl carbamate or urea derivative or a pharmaceutically acceptable salt thereof selectively inhibits cathepsin K, and thus can be useful in the prevention or treatment of osteoporosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/